Lyphe, a London, UK-based medical cannabis ecosystem providing patient care, medical treatments and direct-2-patient digital services, closed a £5m financing round.
The round was led by Leafy Tunnel with participation from Sharp Capital Advisors, and a syndicate of HNW investors.
The company intends to use the funds for expansion into multiple markets across Europe.
Lyphe CEO Jonathan Nadler, Lyphe has built a digital first patient-access ecosystem that provides clinics, dispensing, import infrastructure and vital educational services to patients, doctors and the industry. The company has more than 100 team members working across telehealth, dispensing and technology services.
The £5m Series A investment round follows a 2021 for Lyphe Group which saw them increase their revenues by more than 250% y-o-y.